The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS2-7

Risk management of tumor lysis syndrome（TLS）

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Keita Kirito (Department of Hematology and Oncology, University of Yamanashi)

Sponsor: Sanofi K.K.

[MS2-7] Risk management of tumor lysis syndrome（TLS）

Takahiro Yamauchi (Department of Hematology and Oncology, University of Fukui)